References 327 Medved , L. , and Niewenhuizen , W. ( 2003 ). Molecular mechanisms <strong>of</strong> initiation <strong>of</strong> fibrinolysis by fibrin . Thromb. Haemost. 89 , 409 – 419 . Meijers , J. C. , Marquart , J. A. , Bertina , R. M. , Bouma , B. N. , and Rosendaal , F. R. ( 2002 ). Protein C inhibitor (plasminogen activator inhibitor-3) and the risk <strong>of</strong> venous thrombosis . Br. J. Hematol. 118 , 604 – 609 . Meyers , K. , and Wardrop , K. J. ( 1991 ). Platelets and coagulation . Adv. Vet. Sci. Comp. Med. 36 , 87 – 150 . Meyers , K. M. , Seachord , C. L. , Holmsen , H. , and Prieur , D. J. ( 1981 ). Evaluation <strong>of</strong> the platelet storage pool deficiency in the feline counterpart <strong>of</strong> the Chediak-Higashi syndrome . Am. J. Hematol. 11 , 241 – 253 . Meyers , K. M. , Wardrop , K. J. , Dodds , W. J. , and Brassard , J. ( 1990 a ). Effect <strong>of</strong> exercise, DDAVP, and epinephrine on the Factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Doberman pinscher dogs . Thromb. Res. 57 , 97 – 108 . Meyers , K. M. , Wardrop , K. J. , Helmick , C. , and White , F. ( 1990 b ). von Willebrand factor is present in the vascular endothelium from normal dogs and from Doberman pinscher dogs with a plasma von Willebrand factor deficiency . Thromb. Res. 57 , 109 – 116 . Miesner , M. D. , and Anderson , D. E. ( 2006 ). Factor VIII deficiency in a newborn alpaca . J. Vet. Intern. Med. 20 , 1248 – 1250 . Mills , D. C. B. ( 1996 ). ADP receptors on platelets . Thromb. Haemost. 76 , 835 – 856 . Mills , D. L. , Hawkins , E. , Jager , M. , and Boyle , C. R. ( 1995 ). Comparison <strong>of</strong> coagulation test results for blood samples obtained by means <strong>of</strong> direct venipuncture and through a jugular vein catheter in clinically normal dogs . J. Am. Vet. Med. Assoc. 207 , 1311 – 1314 . Mills , J. N. , Labuc , R. H. , and Lawley , M. J. (1997 ). Factor VII deficiency in an Alaskan malamute . Aust. Vet. J. 75 , 320 – 324 . Minnema , M. C. , ten Cate , H. , and Hack , E. ( 1999 ). The role <strong>of</strong> factor XI in coagulation: a matter <strong>of</strong> revision . Sem. Thromb. Hemost. 25 , 419 – 428 . Mischke , R. ( 2000 ). Activated partial thromboplastin time as a screening test <strong>of</strong> minor or moderate coagulation factor deficiencies for canine plasma: sensitivity <strong>of</strong> different commercial reagents . J. Vet. Diagn. Invest. 12 , 433 – 437 . Mischke , R. ( 2002 ). Commercial variants <strong>of</strong> the prothrombin time test as a screening test <strong>of</strong> acquired coagulation factor II, VII, and X deficiencies in dogs . Res. Vet. Sci. 73 , 165 – 170 . Mischke , R. ( 2003 ). Heparin in vitro sensitivity <strong>of</strong> the activated partial thromboplastin time in canine plasma depends on reagent . J. Vet. Diagn. Invest. 15 , 588 – 591 . Mischke , R. , Diedrich , M. , and Nolte , I. ( 2003 ). Sensitivity <strong>of</strong> different prothrombin time assays to factor VII deficiency in canine plasma . Vet. J. 166 , 79 – 85 . Mischke , R. , and Jacobs , C. ( 2001 ). The monitoring <strong>of</strong> heparin administration by screening tests in experimental dogs . Res. Vet. Sci. 70 , 101 – 108 . Mischke , R. , and Keidel , A. (2003 ). Influence <strong>of</strong> platelet count, acetylsalicylic acid, von Willebrand’s disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs . Vet. J. 165 , 43 – 52 . Mischke , R. , and Nolte , I. ( 1997 ). Optimization <strong>of</strong> prothrombin time measurements in canine plasma . Am. J. Vet. Res. 58 , 236 – 241 . Mischke , R. , and Schulze , U. (2004 ). Studies on platelet aggregation using the Born method in normal and uraemic dogs . Vet. J. 168 , 270 –275 . Moir , E. , Robbie , L. A. , Bennett , B. , and Booth , N. A. ( 2002 ). Polymorphonuclear leucocytes have two opposing roles in fibrinolysis . Thromb. Haemost. 87 , 1006 – 1010 . Moncada , S. , and Vane , J. R. ( 1976 ). Arachidonic acid metabolites and the interaction between platelets and blood vessel walls . New Engl. J. Med. 300 , 1141 – 1146 . Monreal , L. ( 2003 ). D-dimer as a new test for the diagnosis <strong>of</strong> DIC and thromboembolic diseases . J. Vet. Intern. Med. 17 , 757 – 759 . Monroe , D. M. , and H<strong>of</strong>fman , M. ( 2006 ). What does it take to make the perfect clot Arterioscler . Thromb. Vasc. Biol. 26 , 41 – 48 . Monroe , D. M. , and Key , N. S. ( 2007 ). The tissue factor-FVIIa complex: complex: procoagulant activity, regulation, and multitasking . J. Thromb. Haemost. 5 , 1097 – 1105 . Morales , F. , Couto , C. G. , and Iazbik , M. C. ( 2007 ). Effects <strong>of</strong> 2 concentrations <strong>of</strong> sodium citrate on coagulation test results, von Willebrand factor concentration, and platelet function in dogs . J. Vet. Intern. Med. 21 , 472 – 475 . Moreno , P. , and Ginel , P. J. ( 1999 ). Effects <strong>of</strong> haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs . Res. Vet. Sci. 67 , 273 – 276 . Moritz , A. , Walcheck , B. K. , Deye , J. , and Weiss , D. J. ( 2003 a ). Effects <strong>of</strong> short-term racing activity on platelet and neutrophil activation in dogs . Am. J. Vet. Res. 64 , 855 – 859 . Moritz , A. , Walcheck , B. K. , and Weiss , D. J. ( 2003 b ). Flow cytometric detection <strong>of</strong> activated platelets in the dog . Vet. Clin. Pathol. 32 , 6 – 12 . Moser , J. , Meyers , K. M. , Russon , R. H. , and Reeves , J. J. ( 1998 ). Plasma von Willebrand factor changes during various reproductive cycle stages in mixed-breed dogs with normal von Willebrand factor and in Doberman Pinschers with type-I von Willebrand’s disease . Am. J. Vet. Res. 59 , 111 – 118 . Mosesson , M. W. ( 1992 ). The roles <strong>of</strong> fibrinogen and fibrin in hemostasis and thrombosis. Semin . Hematol. 29 , 177 – 188 . Mosnier , L. O. , Lisman , T. , van den Berg , H. M. , Nieuwenhuis , H. K. , Meijers , J. C. M. , and Bouma , B. N. ( 2001 ). The defective down regulation <strong>of</strong> fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration . Thromb. Haemost. 86 , 1035 – 1039 . Munday , J. S. , and Thompson , L. J. ( 2003 ). Brodifacoum toxicosis in two neonatal puppies . Vet. Pathol. 40 , 216 – 219 . Munoz , E. M. , and Linhardt , R. J. ( 2004 ). Heparin-binding domains in vascular biology . Arterioscler. Thromb. Vasc. Biol. 24 , 1549 – 1557 . Murphy , M. J. (2002 ). Rodenticides . Vet. Clin. North Am. Small Anim. Pract. 32 , 469 – 484 . Nagata , Y. , Yoshikawa , J. , Hashimoto , A. , Yamamoto , M. , Payne , A. H. , and Todokoro , K. (2003 ). Proplatelet formation <strong>of</strong> megakaryocytes is triggered by autocrine-synthesized estradiol . Genes Dev. 17 , 2864 –2869 . Nakata , M. , Sakai , M. , and Sakai , T. ( 2006 ). Hemophilia B in a crossbred Maltese dog . J. Vet. Med. Sci. 68 , 1223 – 1224 . Narita , M. , Rudolph , A. E. , Miletich , J. P. , and Schwartz , A. L. ( 1998 ). The low-density lipoprotein receptor-related protein (LPR) mediates clearance <strong>of</strong> coagulation factor Xa in vivo . Blood 91 , 555 – 560 . Neer , T. M. , and Savant , R. L. ( 1992 ). Hypoprothrombinemia secondary to administration <strong>of</strong> sulfaquinoxaline to dogs in a kennel setting . J. Am. Vet. Med. Assoc. 200 , 1344 – 1345 . Nelson , O. L. , and Andreasen , C. ( 2003 ). The utility <strong>of</strong> plasma D-dimer to identify thromboembolic disease in dogs . J. Vet. Intern. Med. 17 , 830 – 834 . Nesheim , M. ( 2003 ). Thrombin and fibrinolysis . Chest 124 , 33S – 39S . Newman , P. J. ( 1999 ). Switched at birth: a new family for PECAM-1 . J. Clin. Invest. 103 , 5 – 9 . Newman , P. J. , and Newman , D. K. ( 2003 ). Signal transduction pathways mediated by PECAM-1 . Arterioscler. Thromb. Vasc. Biol. 23 , 953 – 964 .
328 Chapter | 10 Hemostasis Nielsen , L. A. , Zois , N. E. , Pedersen , H. D. , Olsen , L. H. , and Tarnow , I. ( 2007 ). Platelet function in dogs: breed differences and effect <strong>of</strong> acetylsalicylic acid administration . Vet. Clin. Pathol. 36 , 267 – 273 . Nieswandt , B. , and Watson , S. P. ( 2003 ). Platelet-collagen interaction: is GPVI the central receptor Blood 102 , 449 – 461 . Novotny , W. F. , Brown , S. G. , Miletich , J. P. , Rader , D. J. , and Broze , G. J. ( 1991 ). Plasma antigen levels <strong>of</strong> the lipoprotein-associated coagulation inhibitor in patient samples . Blood 78 , 387 – 393 . Novotny , W. F. , Girard , T. J. , Miletich , J. P. , and Broze , G. J. ( 1988 ). Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein-associated coagulation inhibitor from human plasma . Blood 72 , 2020 – 2025 . Nozawa , Y. , Nakashima , S. , and Nagata , K. (1991 ). Phospholipid-mediated signaling in receptor activation <strong>of</strong> human platelets . Biochimica et Biophysica Acta 1082 , 219 – 238 . O’Brien , S. R. , Sellers , T. S. , and Meyer , D. J. ( 1995 ). Artifactual prolongation <strong>of</strong> the activated partial thromboplastin time associated with hemoconcentration in dogs . J. Vet. Intern. Med. 9 , 169 – 170 . Ogawa , T. , Sugidachi , A. , Asai , F. , and Koike , H. (1998 ). Involvement <strong>of</strong> platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets . Blood Coagul. Fibrinolysis 9 , 233 – 240 . Olson , S. T. , and Shore , J. D. ( 1982 ). Demonstration <strong>of</strong> a two-step reaction mechanism for inhibition <strong>of</strong> alpha-thrombin by antithrombin III and identification <strong>of</strong> the step affected by heparin . J. Biol. Chem. 257 , 14891 – 14895 . Orth , K. , Madison , E. L. , Genthing , M.-J. , Sambrook , J. F. , and Herz , J. (1992 ). Complexes <strong>of</strong> tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means <strong>of</strong> the low density lipoprotein receptor-related protein/ α 2 -macroglobulin receptor . Proc. Natl. Acad. Sci. USA 89 , 7422 –7426 . Osdoit , S. , and Rosa , J. P. ( 2001 ). Fibrin clot retraction by human platelets correlates with α IIb β 3 integrin-dependent protein tyrosine dephosphorylation . J. Biol. Chem. 276, 6703–6710 . Otto , C. M. , Dodds , W. J. , and Greene , C. E. ( 1991 ). Factor XII and partial prekallikrein deficiencies in a dog with recurrent gastrointestinal hemorrhage . J. Am. Vet. Med. Assoc. 198 , 129 – 131 . Otto , C. M. , Rieser , T. M. , Brooks , M. B. , and Russell , M. W. ( 2000 ). Evidence <strong>of</strong> hypercoagulability in dogs with parvoviral enteritis . J. Am. Vet. Med. Assoc. 217 , 1500 – 1504 . Paczuski , R. ( 2002 ). Determination <strong>of</strong> von Willebrand factor activity with collagen-binding assay and diagnosis <strong>of</strong> von Willebrand disease: effect <strong>of</strong> collagen source and coating conditions . J. Lab. Clin. Med. 140 , 250 – 254 . Park , B. K. , and Leck , J. B. ( 1982 ). A comparison <strong>of</strong> vitamin K antagonism by warfarin, difenacoum and brodifacoum in the rabbit . Biochem. Pharmacol. 31 , 3635 – 3639 . Patil , S. , Newman , D. K. , and Newman , P. J. ( 2001 ). Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen . Blood 97 , 1727 – 1732 . Pelagalli , A. , Lombardi , P. , d’Angelo , D. , Della Morte , R. , Avallone , L. , and Staiano , N. (2002 ). Species variability in platelet aggregation response to different agonists . J. Comp. Pathol. 127 , 126 – 132 . Pereira , J. , Soto , M. , Palomo , I. , Ocqueteau , M. , Coetzee , L. M. , Astudillo , S. , Aranda , E. , and Mezzano , D. ( 2002 ). Platelet aging in vivo is associated with activation <strong>of</strong> apoptotic pathways: studies in a model <strong>of</strong> suppressed thrombopoiesis in dogs . Thromb. Haemost. 87 , 905 – 909 . Pike , R. N. , Buckle , A. M. , le Bonniec , B. F. , and Church , F. D. ( 2005 ). Control <strong>of</strong> the coagulation system by serpins . FEBS J. 272 , 4842 – 4851 . Pixley , R. A. , De La Cadena , R. , Page , J. D. , Kaufman , N. , Wyshock , E. G. , Chang , A. , Taylor , F. B. , Jr , and Colman , R. W. (1993 ). The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia in vivo use <strong>of</strong> monoclonal anti-factor XII antibody to block contact activation in baboons. J. Clin. Invest. 91 , 61 – 68 . Pixley , R. A. , Schapira , M. , and Colman , R. W. ( 1985 ). The regulation human factor XII a by plasma proteinase inhibitors . J. Biol. Chem. 260 , 1723 – 1729 . Polasek , J. ( 2004 ). Procoagulation potential <strong>of</strong> platelet alpha granules . Platelets 15 , 403 – 407 . Ponting , C. P. , Marshal , J. M. , and Cederholm-Williams , S. A. ( 1992 ). Plasminogen: a structural review . Blood Coagul. Fibrinolysis 3 , 605 – 614 . Pratt , C. W. , and Church , F. C. ( 1992 ). Heparin binding to protein C inhibitor . J. Biol. Chem. 267 , 8789 – 8794 . Prescott , S. M. , Zimmerman , G. A. , Stafforini , D. M. , and McIntyre , T. M. ( 2000 ). Platelet-activating factor and related lipid mediators . Ann. Rev. Biochem. 69 , 419 – 445 . Preusch , P. C. , Hazelett , S. E. , and Lemasters , K. K. ( 1989 ). Sulfaquinoxaline inhibition <strong>of</strong> vitamin K expoxide and quinone reductase . Arch. Biochem. Biophys. 269 , 18 – 24 . Prevost , N. , Woulfe , D. S. , Tognolini , M. , Tanaka , T. , Jian , W. , Fortna , R. R. , Jiang , H. , and Brass , L. F. ( 2004 ). Signaling by ephrin B1 and Eph kinases in platelets promotes Rap1 activation, platelet adhesion, and aggregation via effector pathways that do not require phosphorylation <strong>of</strong> ephrin B1 . Blood 103 , 1348 – 1355 . Puri , R. N. ( 1998 ). Phospholipase A2: its role in ADP- and thrombininduced platelet activation mechanisms . Int. J. Biochem. Cell Biol. 30 , 1107 – 1122 . Randolph , J. F. , Center , S. A. , and Dodds , W. J. ( 1986 ). Factor XII deficiency and von Willebrand’s disease in a family <strong>of</strong> miniature poodle dogs . The Cornell Veterinarian 76 , 3 – 10 . Ravetch , J. V. , and Lanier , L. L. ( 2000 ). Immune inhibitory receptors . Science 290 , 84 – 89 . Reed , G. L. ( 2004 ). Platelet secretory mechanisms . Semin. Thromb. Hemost. 30 , 441 – 450 . Rendu , F. , and Brohard-Bohn , B. ( 2001 ). The platelet release reaction: granules ’ constituents, secretion and functions . Platelets 12 , 261 – 273 . Rezaie , A. R. ( 1998 ). Calcium enhances heparin catalysis <strong>of</strong> the antithrombin-factor Xa reaction by a template mechanism: evidence that calcium alleviates Gla domain antagonism <strong>of</strong> heparin binding to Factor Xa . J. Biol. Chem. 273 , 16824 – 16827 . Rickles , F. R. , and Falanga , A. (2001 ). Molecular basis for the relationship between thrombosis and cancer . Thromb. Res. 102 , V215 –V224 . Rittenhouse , S. E. ( 1996 ). Phosphoinositide 3-kinase activation and platelet function . Blood 88 , 4401 – 4414 . Robinson , A. J. , Kropatkin , M. , and Aggeler , P. M. ( 1969 ). Hageman factor (factor XII) deficiency in marine mammals . Science 166 , 1420 – 1422 . Rojkjaer , R. , and Schmaier , A. H. ( 1999 ). Activation <strong>of</strong> the plasma kallikrein/kinin system on endothelial cell membranes . Immunopharmacol. 43 , 109 – 114 . Roncales , F. J., and Sancho , J. M. (2000 ). Coagulation activators . In “Schalm’s Veterinary Hematology ” (B. F. Feldman , J. G. Zinkl , and N. C. Jain , Eds.) , 5th ed . , pp. 532 –537 . Lippincott Williams and Wilkins , Philadelphia . Roy , S. N. , Procyk , R. , Kudryk , B. J. , and Redman , C. M. ( 1991 ). Assembly and secretion <strong>of</strong> recombinant human fibrinogen . J. Biol. Chem. 266 , 4758 – 4763 .
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276: VIII. Disorders of Iron Metabolism
- Page 277 and 278: VIII. Disorders of Iron Metabolism
- Page 279 and 280: References 279 ( Norrdin et al ., 2
- Page 281 and 282: References 281 Fresco , R. ( 1981 )
- Page 283 and 284: References 283 Moore , C. V. , Duba
- Page 285 and 286: References 285 Weiden , P. L. , Hac
- Page 287 and 288: 288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290: 290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292: 292 Chapter | 10 Hemostasis The pro
- Page 293 and 294: 294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296: 296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298: 298 Chapter | 10 Hemostasis that is
- Page 299 and 300: 300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302: 302 Chapter | 10 Hemostasis However
- Page 303 and 304: 304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306: 306 Chapter | 10 Hemostasis is a re
- Page 307 and 308: 308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310: 310 Chapter | 10 Hemostasis necessi
- Page 311 and 312: 312 Chapter | 10 Hemostasis disease
- Page 313 and 314: 314 Chapter | 10 Hemostasis concent
- Page 315 and 316: 316 Chapter | 10 Hemostasis the rol
- Page 317 and 318: 318 Chapter | 10 Hemostasis proport
- Page 319 and 320: 320 Chapter | 10 Hemostasis a consi
- Page 321 and 322: 322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324: 324 Chapter | 10 Hemostasis Dowd ,
- Page 325: 326 Chapter | 10 Hemostasis Kier ,
- Page 329 and 330: 330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332: 332 Chapter | 11 Neutrophil Functio
- Page 333 and 334: 334 Chapter | 11 Neutrophil Functio
- Page 335 and 336: 336 Chapter | 11 Neutrophil Functio
- Page 337 and 338: 338 Chapter | 11 Neutrophil Functio
- Page 339 and 340: 340 Chapter | 11 Neutrophil Functio
- Page 341 and 342: 342 Chapter | 11 Neutrophil Functio
- Page 343 and 344: 344 Chapter | 11 Neutrophil Functio
- Page 345 and 346: 346 Chapter | 11 Neutrophil Functio
- Page 347 and 348: 348 Chapter | 11 Neutrophil Functio
- Page 349 and 350: 350 Chapter | 11 Neutrophil Functio
- Page 351 and 352: 352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354: 354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356: 356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358: 358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360: 360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362: 362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364: 364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366: 366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368: 368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370: 370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372: 372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374: 374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376: 376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428:
428 Chapter | 14 Gastrointestinal F
- Page 429 and 430:
430 Chapter | 14 Gastrointestinal F
- Page 431 and 432:
432 Chapter | 14 Gastrointestinal F
- Page 433 and 434:
434 Chapter | 14 Gastrointestinal F
- Page 435 and 436:
436 Chapter | 14 Gastrointestinal F
- Page 437 and 438:
438 Chapter | 14 Gastrointestinal F
- Page 439 and 440:
440 Chapter | 14 Gastrointestinal F
- Page 441 and 442:
442 Chapter | 14 Gastrointestinal F
- Page 443 and 444:
444 Chapter | 14 Gastrointestinal F
- Page 445 and 446:
446 Chapter | 14 Gastrointestinal F
- Page 447 and 448:
448 Chapter | 14 Gastrointestinal F
- Page 449 and 450:
450 Chapter | 14 Gastrointestinal F
- Page 451 and 452:
452 Chapter | 14 Gastrointestinal F
- Page 453 and 454:
454 Chapter | 14 Gastrointestinal F
- Page 455 and 456:
456 Chapter | 14 Gastrointestinal F
- Page 457 and 458:
Chapter 15 Skeletal Muscle Function
- Page 459 and 460:
II. Specialization of the Sarcolemm
- Page 461 and 462:
II. Specialization of the Sarcolemm
- Page 463 and 464:
III. Heterogeneity of Skeletal Musc
- Page 465 and 466:
III. Heterogeneity of Skeletal Musc
- Page 467 and 468:
V. Exercise and Adaptations to Trai
- Page 469 and 470:
VI. Diagnostic Laboratory Methods f
- Page 471 and 472:
VI. Diagnostic Laboratory Methods f
- Page 473 and 474:
IX. Selected Neuromuscular Disorder
- Page 475 and 476:
IX. Selected Neuromuscular Disorder
- Page 477 and 478:
References 479 and, recently, there
- Page 479 and 480:
References 481 Engel , A. G. ( 2004
- Page 481 and 482:
References 483 Paciello , O. , Maio
- Page 483 and 484:
Chapter 16 Kidney Function and Dama
- Page 485 and 486:
II. Kidney Morphology and Function
- Page 487 and 488:
II. Kidney Morphology and Function
- Page 489 and 490:
III. Tests of Kidney Function 491 (
- Page 491 and 492:
III. Tests of Kidney Function 493 T
- Page 493 and 494:
III. Tests of Kidney Function 495 B
- Page 495 and 496:
6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498:
III. Tests of Kidney Function 499 d
- Page 499 and 500:
IV. Tests of Kidney Damage 501 1000
- Page 501 and 502:
IV. Tests of Kidney Damage 503 and
- Page 503 and 504:
IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506:
V. Biochemical Changes in Kidney Di
- Page 507 and 508:
V. Biochemical Changes in Kidney Di
- Page 509 and 510:
References 511 were reported to occ
- Page 511 and 512:
References 513 Bovee , K. C. ( 1969
- Page 513 and 514:
References 515 Deguchi , E. , and A
- Page 515 and 516:
References 517 Fleming , S. A. , Hu
- Page 517 and 518:
References 519 Harvey , D. G. ( 197
- Page 519 and 520:
References 521 Kühl , S. , Mischke
- Page 521 and 522:
References 523 creatinine measureme
- Page 523 and 524:
References 525 Reusch , C. , Vochez
- Page 525 and 526:
References 527 Terry , R. , Hawkins
- Page 527 and 528:
Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531:
532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535:
536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537:
538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539:
540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541:
542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543:
544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545:
546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547:
548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549:
550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552:
VIII. Clinicopathological Indicator
- Page 553 and 554:
References 555 plasma water, electr
- Page 555 and 556:
References 557 Krzywanek , H. ( 197
- Page 557 and 558:
References 559 Strombeck , D. R. (1
- Page 559 and 560:
562 Chapter | 18 Pituitary Function
- Page 561 and 562:
564 Chapter | 18 Pituitary Function
- Page 563 and 564:
566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl